We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.85B
1-Year Est. Return 140.52%
This Fund
S&P 500
This Quarter Est. Return
+6.53%
1 Year Est. Return
+140.52%
3 Year Est. Return
+478.17%
5 Year Est. Return
+660.56%
10 Year Est. Return
+4,974.42%
AUM
$1.58B
AUM Growth
-$143M
Cap. Flow
-$168M
Cap. Flow %
-10.64%
Top 10 Hldgs %
18.89%
Holding
232
New
21
Increased
61
Reduced
99
Closed
18

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$16.3M
2
AHCO icon
AdaptHealth
AHCO
+$14.4M
3
CELH icon
Celsius Holdings
CELH
+$14.3M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$11.8M
5
NOG icon
Northern Oil and Gas
NOG
+$11.5M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$22.5M
2
AVNT icon
Avient
AVNT
+$20M
3
ALKS icon
Alkermes
ALKS
+$18.8M
4
GTLS
Chart Industries
GTLS
+$14.2M
5
ONTO icon
Onto Innovation
ONTO
+$13.1M

Sector Composition

Rank Sector Weight
1 Healthcare 29.23%
2 Financials 15.84%
3 Industrials 14.44%
4 Technology 12.81%
5 Consumer Discretionary 12.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMCG
226
DELISTED
MILLENNIUM INDIA ACQUISITION CO INC COM STK
SMCG
– –
-328,609
Closed -$194K
BHVN
227
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-154,634
Closed -$22.5M
6 7 8 9
10

Similar funds

SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
YC
Yarbrough Capital Franklin, Tennessee $2.85B AUM 36.22% 1-Year Est. Return
AHSSHC
Adventist Health System Sunbelt Healthcare Corp Altamonte Springs, Florida $2.86B AUM 12.86% 1-Year Est. Return
CAM
Crake Asset Management London, United Kingdom $2.86B AUM 16.35% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's Q3 2022 Portfolio in Review

As of Q3 2022, Emerald Mutual Fund Advisers Trust held 232 positions worth $1.58B, down 8.3% from $1.73B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Mutual Fund Advisers Trust withdrew a net $168M in Q3 2022, closing 18 positions and reducing 99 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $22.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.

Against the trend, Emerald Mutual Fund Advisers Trust opened a new position in Blueprint Medicines worth $16.7M.

  • Emerald Mutual Fund Advisers Trust's largest Q3 2022 buy was Blueprint Medicines: 253,645 shares worth $16.7M.
  • Emerald Mutual Fund Advisers Trust added most to Northern Oil and Gas in Q3 2022, an estimated $11.5M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q3 2022 reduction was Avient, cutting an estimated $20M.
  • Emerald Mutual Fund Advisers Trust fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $22.5M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 19% of its $1.58B portfolio in Q3 2022.
  • Emerald Mutual Fund Advisers Trust opened 21 new positions and closed 18 in Q3 2022.
  • Emerald Mutual Fund Advisers Trust's portfolio value fell 8.3% quarter-over-quarter to $1.58B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2022, filed 25 Oct 2022.